Posted on 04/16/2021 9:59:01 AM PDT by SeekAndFind
The European Union is very unlikely to renew its Covid-19 vaccine contracts with pharmaceutical company AstraZeneca, a French minister said on Friday. Denmark this week banned the use of AstraZeneca jabs over blood clot concerns, just as the EU said it was expecting 50 million Pfizer vaccine doses earlier than expected.
No final EU decision had been taken, French Industry Minister Agnes Pannier-Runacher told RMC radio, but “it is highly probable” that no further AstraZeneca doses would be ordered for 2022.
“We have not started talks with Johnson & Johnson or with AstraZeneca for a new contract, but we have started talks with Pfizer/BioNTech and Moderna,” Pannier-Runacher said.
AstraZeneca has had major problems in fulfilling its orders to the EU, with the Bloc ending up with many million fewer doses of the vaccine than it was expecting in the first two quarters, which has had an effect on the speed of the rollout across EU countries.
Denmark said on Wednesday it would stop using the AstraZeneca vaccine altogether over blood clot fears, despite assurances from the EMA and the World Health Organization that the benefits far outweigh possible risks.
Switzerland has never licensed the AstraZeneca vaccine for use and most other European countries now restrict the vaccine only to the older population, who appear to be less at risk from the rare blood clots that have been associated with it.
(Excerpt) Read more at thelocal.fr ...
Every experiment needs a control group. I’ll be in the control group.
Let’s see how fast BioNTech SE ramps up production of the Pfizer/BioNTech vaccine in Europe....
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.